drugset / Trial / NCT02672306
Safety and Exploratory Efficacy Study of UCMSCs in Patients With Alzheimer's Disease
Phase 1/2
Unknown
16 enrolled
South China Research Center for Stem Cell and Regenerative Medicine
Guangzhou General Hospital of Guangzhou Military Command · collabThird Affiliated Hospital, Sun Yat-Sen University · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary purpose of this study is to evaluate the safety and the efficacy of (Human Umbilical Cord-Derived Mesenchymal Stem Cells) UCMSCs for patients with Alzheimer's disease (AD).
Timeline
- Start
- 2017-10-20
- Primary completion
- 2018-10
- Completion
- 2019-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mesenchymal stem cells | Cell therapy | 500000 cells/kg | Intravenous |
| Subject | mesenchymal stem cells | Cell therapy | 2e+07 cells | Intravenous |